Sharareh Gholamin
City Of Hope National Medical Center(US)City of Hope(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Glioma Diagnosis and Treatment, CAR-T cell therapy research, Chromatin Remodeling and Cancer, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors(2017)417 cited
- → BET Bromodomain Inhibition of MYC -Amplified Medulloblastoma(2013)346 cited
- → Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo(2016)325 cited
- → Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition(2014)312 cited
- → Immune Evasion Strategies of Glioblastoma(2016)258 cited
- → Gpr124 is essential for blood–brain barrier integrity in central nervous system disease(2017)254 cited
- → Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma(2019)245 cited
- → MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma(2015)184 cited
- → IFNγ Is Critical for CAR T Cell–Mediated Myeloid Activation and Induction of Endogenous Immunity(2021)160 cited
- → GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma(2017)105 cited